Myocardial ANP expression in Pompe's disease: An immunohistochemical study

Area of Science:

• Cardiology
• Biochemistry
• Pathology

Background:

• Pompe disease, a glycogen storage disorder, affects cardiac myocytes.
• Myocyte enlargement in Pompe disease is not due to hypertrophy.
• Atrial natriuretic peptide (ANP) is a hormone involved in cardiovascular regulation.

Purpose of the Study:

• To investigate atrial natriuretic peptide (ANP) expression in the myocardium of patients with Pompe disease.
• To determine the relationship between ANP expression, cytoplasmic vacuolization, and myocyte enlargement in Pompe disease.

Main Methods:

• Immunoperoxidase technique used to analyze ANP expression.
• Samples analyzed included atrial and ventricular myocardium from three Pompe disease cases.

Main Results:

• ANP was expressed in atrial myocytes and some subendocardial ventricular myocytes, excluding glycogen-filled vacuoles.
• Ventricular ANP expression was often more pronounced in left ventricular samples.
• ANP distribution in ventricles resembled that seen in other heart diseases, but myocyte enlargement was not hypertrophic.

Conclusions:

• Atrial myocytes in Pompe disease retain ANP expression despite significant cytoplasmic vacuolization.
• Ventricular ANP expression appears linked to mechanical stimuli like increased wall stress, not directly to myocyte hypertrophy.